KELLER WILLIAM R 4
4 · ALEXION PHARMACEUTICALS INC · Filed Feb 24, 2012
Insider Transaction Report
Form 4
KELLER WILLIAM R
Director
Transactions
- Exercise/Conversion
Common Stock, par value $.0001 per share
2012-02-23$26.64/sh+1,984$52,854→ 15,534 total - Exercise/Conversion
Option to Purchase Common Stock
2012-02-23−1,984→ 0 totalExercise: $26.64From: 2010-08-12Exp: 2020-05-12→ Common Stock, par value $.0001 per share (1,984 underlying) - Exercise/Conversion
Common Stock, par value $.0001 per share
2012-02-23$49.43/sh+2,786$137,712→ 18,320 total - Exercise/Conversion
Option to Purchase Common Stock
2012-02-23−3,745→ 3,747 totalExercise: $23.05From: 2010-03-01Exp: 2019-12-01→ Common Stock, par value $.0001 per share (3,745 underlying) - Exercise/Conversion
Common Stock, par value $.0001 per share
2012-02-23$23.05/sh+3,745$86,322→ 13,550 total - Sale
Common Stock, par value $.0001 per share
2012-02-23$84.78/sh−8,515$721,902→ 9,805 total - Exercise/Conversion
Option to Purchase Common Stock
2012-02-23−2,786→ 2,786 totalExercise: $49.43From: 2011-08-11Exp: 2021-05-11→ Common Stock, par value $.0001 per share (2,786 underlying)
Footnotes (1)
- [F1]This transaction was executed in multiple trades through a broker-dealer at prices ranging from $84.67 - $85.03. The price reported in this column reflects the weighted average sales price. Upon request, the reporting person will provide to the SEC staff full information regarding the number of shares sold at each price.